[Treatment of pulmonary infections with cephalexin (author's transl)].
The efficacy of Cephalexin--an oral cephalosporine--was assessed in 20 children with pulmonary infections including bronchopneumonia and infiltrative peribronchitis in an open study. In 16 patients prompt resolution of clinical and radiological signs was observed. The drug was well tolerated, there were no side effects or allergies to be demonstrated. Among the therapeutic agents for infections of the respiratory tract cephalexin should be considered among the antibiotics of first choice.
D001991:Bronchitis / Q000188:drug therapy*; D001996:Bronchopneumonia / Q000188:drug therapy*; D002506:Cephalexin / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004341:Drug Evaluation; D006801:Humans; D007223:Infant; D007709:Klebsiella / Q000302:isolation & purification; D010614:Pharynx / Q000382:microbiology; D013291:Streptococcus / Q000302:isolation & purification
D002506:Cephalexin
Ospexin--eine neue galenische Form der antibakteriellen Wirkungssubstanz Cephalexin.